Cargando…

X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism

[Image: see text] Ruthenium(III) complexes are promising candidates for anticancer drugs, especially the clinically studied indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) and its analogue sodium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (NKP-1339). Several studies have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bijelic, Aleksandar, Theiner, Sarah, Keppler, Bernhard K., Rompel, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2016
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921950/ https://www.ncbi.nlm.nih.gov/pubmed/27196130 http://dx.doi.org/10.1021/acs.jmedchem.6b00600

Ejemplares similares

X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)
por: Hummer, Alfred A., et al.
Publicado: (2013)

Solvolysis of the Tumor-Inhibiting Ru(III)-Complex trans-Tetrachlorobis(Indazole)Ruthenate(III)
por: Pieper, Thomas, et al.
Publicado: (2000)

Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion
por: Bergamo, A., et al.
Publicado: (2009)

DMSO reduces the cytotoxicity of anticancer ruthenium complex KP1019 in yeast
por: Davis, Jonathan, et al.
Publicado: (2021)

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliumtetrachlorobis-(1-Methylindazole)Ruthenate(III) and its Hydrolysis Product trans-Monoaquatrichlorobis-(1-Methylindazole)-Ruthenate(III)
por: Lipponer, Kari-Georg, et al.
Publicado: (1996)

Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse
por: Blazevic, Amir, et al.
Publicado: (2017)

Binding of a Fatty Acid-Functionalized Anderson-Type Polyoxometalate to Human Serum Albumin
por: Bijelic, Aleksandar, et al.
Publicado: (2020)

NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
por: Alessio, Enzo, et al.
Publicado: (2019)

En Route to Osmium Analogues of KP1019: Synthesis, Structure, Spectroscopic Properties and Antiproliferative Activity of trans-[Os(IV)Cl(4)(Hazole)(2)]
por: Büchel, Gabriel E., et al.
Publicado: (2011)

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo()
por: Heffeter, Petra, et al.
Publicado: (2013)

DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae
por: Bierle, Lindsey A., et al.
Publicado: (2015)

Photostriction of strontium ruthenate
por: Wei, Tzu-Chiao, et al.
Publicado: (2017)

Correction: DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae
Publicado: (2015)

A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)
por: Golla, Upendarrao, et al.
Publicado: (2017)

Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins
por: Messori, L., et al.
Publicado: (2000)

The use of polyoxometalates in protein crystallography – An attempt to widen a well-known bottleneck
por: Bijelic, Aleksandar, et al.
Publicado: (2015)

Polyoxometalates: more than a phasing tool in protein crystallography
por: Bijelic, Aleksandar, et al.
Publicado: (2018)

Ten Good Reasons for the Use of the Tellurium-Centered Anderson–Evans Polyoxotungstate in Protein Crystallography
por: Bijelic, Aleksandar, et al.
Publicado: (2017)

Adsorption of Water at the SrO Surface of Ruthenates
por: Halwidl, Daniel, et al.
Publicado: (2015)

Colossal negative thermal expansion in reduced layered ruthenate
por: Takenaka, Koshi, et al.
Publicado: (2017)

The crystallization additive hexatungstotellurate promotes the crystallization of the HSP70 nucleotide binding domain into two different crystal forms
por: Mac Sweeney, Aengus, et al.
Publicado: (2018)

In situ formation of the first proteinogenically functionalized [TeW(6)O(24)O(2)(Glu)](7–) structure reveals unprecedented chemical and geometrical features of the Anderson-type cluster
por: Molitor, Christian, et al.
Publicado: (2016)

The potential of hexatungstotellurate(VI) to induce a significant entropic gain during protein crystallization
por: Molitor, Christian, et al.
Publicado: (2017)

The antibacterial activity of polyoxometalates: structures, antibiotic effects and future perspectives
por: Bijelic, Aleksandar, et al.
Publicado: (2018)

Biochemical and structural characterization of tomato polyphenol oxidases provide novel insights into their substrate specificity
por: Kampatsikas, Ioannis, et al.
Publicado: (2019)

Polyoxometalates as Potential Next‐Generation Metallodrugs in the Combat Against Cancer
por: Bijelic, Aleksandar, et al.
Publicado: (2018)

Heterologous expression and characterization of functional mushroom tyrosinase (AbPPO4)
por: Pretzler, Matthias, et al.
Publicado: (2017)

Theoretical Studies on the Binding Mode and Reaction Mechanism of TLP Hydrolase kpHIUH
por: Wang, Xixi, et al.
Publicado: (2021)

Binding of Apo and Glycated Human Serum Albumins to an Albumin-Selective Aptamer-Bound Graphene Quantum Dot Complex
por: Sittiwanichai, Sirin, et al.
Publicado: (2023)

Reaction between Indazole and Pd-Bound Isocyanides—A Theoretical Mechanistic Study
por: Casella, Girolamo, et al.
Publicado: (2018)

Metal Ruthenate Perovskites as Heterogeneous Catalysts for the Hydrolysis of Ammonia Borane
por: Badding, Catherine K., et al.
Publicado: (2018)

First-Principles Correlated Approach to the Normal State of Strontium Ruthenate
por: Acharya, S., et al.
Publicado: (2017)

Tricyanidoferrates(−IV) and Ruthenates(−IV) with Non‐Innocent Cyanido Ligands
por: Jach, Franziska, et al.
Publicado: (2021)

Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome
por: Fender, Anke C., et al.
Publicado: (2019)

Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC–ICP–MS
por: Klose, Matthias H. M., et al.
Publicado: (2018)

Crystallization and preliminary X-ray crystallographic analysis of polyphenol oxidase from Juglans regia (jrPPO1)
por: Zekiri, Florime, et al.
Publicado: (2014)

A Peptide‐Induced Self‐Cleavage Reaction Initiates the Activation of Tyrosinase
por: Kampatsikas, Ioannis, et al.
Publicado: (2019)

In crystallo activity tests with latent apple tyrosinase and two mutants reveal the importance of the mutated sites for polyphenol oxidase activity
por: Kampatsikas, Ioannis, et al.
Publicado: (2017)

Three recombinantly expressed apple tyrosinases suggest the amino acids responsible for mono- versus diphenolase activity in plant polyphenol oxidases
por: Kampatsikas, Ioannis, et al.
Publicado: (2017)

Conversion of walnut tyrosinase into a catechol oxidase by site directed mutagenesis
por: Panis, Felix, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_39gvgfooip3ureebft8ce3kulm